109 results
POS AM
SPRC
SciSparc Ltd
2 May 24
Prospectus update (post-effective amendment)
5:17pm
are not satisfied or waived, the Merger will not occur or will be delayed, and SciSparc and AutoMax each may lose some or all of the intended benefits … the perceived benefits of the Merger as rapidly or to the extent anticipated by financial or industry analysts;
the effect of the Merger on the combined
425
SPRC
SciSparc Ltd
2 May 24
Business combination disclosure
4:46pm
Liabilities with respect to bonds
Investments in companies treated according to the book value method
Liabilities with respect to employee benefits, net … (decrease) in accounts payable and credit balances
Increase in long-term prepaid expenses
Increase in employee’ benefits and employee related provisions
6-K
EX-99.1
SPRC
SciSparc Ltd
2 May 24
Consolidated Financial Statements as for Consolidated Financial Statements as for To the shareholders of
4:02pm
method
Liabilities with respect to employee benefits, net
Total Equity
Total equity attributed to Company shareholders
Share capital
Share premium
Options … in employee’ benefits and employee related provisions
Increase (decrease) in current payable taxes
The accompanying notes constitute an integral part
20-F/A
2023 FY
SPRC
SciSparc Ltd
2 May 24
Annual report (foreign) (amended)
9:18am
in their economic best interest.
Fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits … employee-benefit plans:
Short-term employee benefits:
Short-term employee benefits are benefits that are expected to be settled wholly before twelve
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
and when the Merger will be consummated; the expected benefits of and potential value created by the proposed Merger for the shareholders of the Company … to be an employee of the Company by any applicable Tax authority; and
(xxiv) the Company did not apply for any tax benefits under the Law for the Encouragement
6-K
EX-99.2
hth9q02ti1e84yse9y0
11 Apr 24
Agreement and Plan of Merger
4:05pm
6-K
hs12a rwlqo4aqxjylfs
11 Apr 24
Agreement and Plan of Merger
4:05pm
6-K
EX-99.1
pdpbzoz17ic57vj2vz
11 Apr 24
Agreement and Plan of Merger
4:05pm
6-K
EX-99.2
7gr mmtbv
8 Mar 24
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
9:00am
F-1
EX-10.7
dddqv3y
27 Feb 24
Registration statement (foreign)
4:15pm
F-1
n7rlio06qrm7cxj2t
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
EX-4.1
7fzf8z 2if4
25 Jan 24
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
9:05am
6-K
EX-4.1
o9fv7s
28 Nov 23
Report of Foreign Private Issuer
4:01pm
6-K
EX-99.1
whcakh4x wdck1
24 Oct 23
SciSparc Granted Patent for its Core Technology From the Australian Patent Office
7:54am
6-K
EX-99.1
puhff5ju2h 07
18 Oct 23
Report of Foreign Private Issuer
6:54am
6-K
EX-4.1
tb0eo ztxd
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am
6-K
EX-10.2
7macknbpthlr
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am
6-K
EX-10.4
s7pmd7z
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am